Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization's updated clinical practice guideline. In a synopsis of the recently ...

In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...

Plasma cystatin C level might better reflect glomerular filtration rate (GFR) than creatinine concentration. Ma et al. have developed and tested a new equation to estimate GFR that uses cystatin C ...

Cystatin C is emphasized as a preferred biomarker for accurate GFR measurement in CKD assessment ... organization updated its 2024 guideline based on an extensive evidence synthesis and meta ...

including imprecision and systematic underestimation of measured GFR at higher levels. 5 Cystatin C blood test is a newer method for estimating eGFR. Although not widely available yet, this test ...

Recommendations include more emphasis on the use of cystatin C for assessment of glomerular filtration rate; use of point ... use of an individualized risk-based approach for prediction of kidney ...